Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear-cell Kidney Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03849118
What this trial is testing

89Zr-TLX250 for PET/CT Imaging of ccRCC- ZIRCON Study

Who this might be right for
Clear Cell Renal Cell Carcinoma
Telix Pharmaceuticals (Innovations) Pty Limited 300
Testing effectiveness (Phase 2)Study completedNCT01693822
What this trial is testing

A Phase II Study of Axitinib in Patients With Metastatic Renal Cell Cancer Unsuitable for Nephrectomy

Who this might be right for
Clear-cell Metastatic Renal Cell Carcinoma
Institute of Cancer Research, United Kingdom 65
Early research (Phase 1)Looking for participantsNCT07517198
What this trial is testing

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

Who this might be right for
Solid TumorSmall Cell Lung Cancer (SCLC)High Grade Neuroendocrine Cancer+9 more
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. 40
Testing effectiveness (Phase 2)Looking for participantsNCT06380816
What this trial is testing

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

Who this might be right for
Advanced Solid TumoursSquamous Cell Carcinoma of Head and NeckCarcinoma, Non-Small-Cell Lung+8 more
Cancer Research UK 167
Testing effectiveness (Phase 2)Study completedNCT00557609
What this trial is testing

Phase 2 Study in Patients With MiT Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Alveolar Soft Part Sarcoma (ASPS)Clear Cell Sarcoma (CCS)
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 47
Not applicableUnknownNCT06317298
What this trial is testing

Fruquintinib Plus Everolimus as 2nd Line Therapy of ccRCC Patients Progressed Post IO and TKI Therapy

Who this might be right for
Renal Cell Carcinoma, Clear Cell, Somatic
Peking University First Hospital 36
Early research (Phase 1)Ended earlyNCT02386111
What this trial is testing

Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal CellKidney DiseasesKidney Neoplasms+6 more
Celldex Therapeutics 17
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07460206
What this trial is testing

Pembrolizumab Plus Lenvatinib in REcurrent ccRCC Patients Failing permbroLizUmab aDjuvant trEatment

Who this might be right for
ccRCC
Gruppo Oncologico Italiano di Ricerca Clinica 108
Testing effectiveness (Phase 2)Temporarily pausedNCT06860386
What this trial is testing

Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCC

Who this might be right for
Renal Cell CarcinomaClear Cell Renal Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 75
Early research (Phase 1)Looking for participantsNCT06242470
What this trial is testing

MGC026 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorAdvanced CancerMetastatic Cancer+19 more
MacroGenics 250
Testing effectiveness (Phase 2)Active Not RecruitingNCT05239533
What this trial is testing

Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaKidney CancerAdvanced Renal Cell Carcinoma
Memorial Sloan Kettering Cancer Center 9
Testing effectiveness (Phase 2)Looking for participantsNCT05127824
What this trial is testing

Autologous Dendritic Cell Vaccine in Kidney Cancer

Who this might be right for
Carcinoma, Renal Cell
Jodi Maranchie 42
Testing effectiveness (Phase 2)Study completedNCT02819596
What this trial is testing

MEDI4736 Combinations in Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Clear Cell CarcinomaRenal Papillary Cell Carcinoma
Queen Mary University of London 69
Early research (Phase 1)Study completedNCT02685553
What this trial is testing

Near Infrared Technology and Laparoscopic Resection of Pancreatic Lesions: the COLPAN Project

Who this might be right for
Pancreatic Neuroendocrine TumorsClear Cell Renal CarcinomaSolid Pseudopapillary Tumors of the Pancreas
Universita di Verona 10
Early research (Phase 1)Looking for participantsNCT04777994
What this trial is testing

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Who this might be right for
Advanced Solid Tumor Cancer
Calico Life Sciences LLC 248
Testing effectiveness (Phase 2)WithdrawnNCT03035630
What this trial is testing

Sunitinib Followed by Avelumab or the Reverse for Metastatic Renal Cell Carcinoma

Who this might be right for
Clear-cell Renal Cell CarcinomaRCCKidney Cancer+1 more
Guru Sonpavde
Testing effectiveness (Phase 2)UnknownNCT04958473
What this trial is testing

Sintilimab in Combination With Axitinib in Advanced Renal Cell Cancer

Who this might be right for
Renal Cell CarcinomaClear Cell Renal Cell Carcinoma
Tianjin Medical University Second Hospital 40
Testing effectiveness (Phase 2)Study completedNCT02667886
What this trial is testing

Trial of X4P-001 in Participants With Advanced Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
X4 Pharmaceuticals 74
Not applicableStudy completedNCT00253383
What this trial is testing

Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients

Who this might be right for
Cancer
Dartmouth-Hitchcock Medical Center 329
Large-scale testing (Phase 3)Ended earlyNCT01599754
What this trial is testing

Adjuvant Axitinib Therapy of Renal Cell Cancer in High Risk Patients

Who this might be right for
Clear Cell Renal Carcinoma
SFJ Pharma Ltd. II 724
Next Page